We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

122 hedge funds and large institutions have $197M invested in Rigel Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 41 increasing their positions, 44 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more call options, than puts

Call options by funds: $57K | Put options by funds: $38K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 123 → 122 (-1)

7% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 44

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

22% less capital invested

Capital invested by funds: $253M → $197M (-$56M)

Holders
122
Holders Change
-1
Holders Change %
-0.81%
% of All Funds
3.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
41
Reduced
44
Closed
10
Calls
$57K
Puts
$38K
Net Calls
+$19K
Net Calls Change
+$253K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$2.6M
2
Axa
Axa
France
+$1.94M
3
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D
New Jersey
+$1.64M
4
NSEDCP
NJ State Employees Deferred Compensation Plan
New Jersey
+$761K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$597K

Top Sellers

1
BC
Broadfin Capital
New York
-$2.24M
2
NI
Numeric Investors
Massachusetts
-$1.14M
3
Two Sigma Investments
Two Sigma Investments
New York
-$886K
4
TC
TFS Capital
Pennsylvania
-$650K
5
OAM
Oxford Asset Management
United Kingdom
-$624K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$1.56M -$190K -6,350 -9%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$1.43M +$86.9K +2,911 +5%
State of New Jersey Common Pension Fund D
28
State of New Jersey Common Pension Fund D
New Jersey
$1.36M +$1.64M +55,000 New
BA
29
BlackRock Advisors
Delaware
$1.17M +$115K +3,860 +9%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.06M -$244K -8,188 -16%
Connor, Clark & Lunn Investment Management (CC&L)
31
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$994K +$465K +15,585 +63%
Renaissance Technologies
32
Renaissance Technologies
New York
$985K +$432K +14,460 +57%
BIM
33
Bogle Investment Management
Massachusetts
$861K -$581K -19,482 -36%
Two Sigma Advisers
34
Two Sigma Advisers
New York
$790K -$97K -3,250 -9%
BIM
35
BlackRock Investment Management
Delaware
$783K -$20K -670 -2%
SIM
36
Spark Investment Management
New York
$768K +$444K +14,870 +91%
WMSA
37
Weiss Multi-Strategy Advisers
New York
$751K +$11.9K +400 +1%
TI
38
Turner Investments
Pennsylvania
$704K – – –
NSEDCP
39
NJ State Employees Deferred Compensation Plan
New Jersey
$630K +$761K +25,500 New
TI
40
Telemetry Investments
New York
$618K – – –
BCM
41
Bridgeway Capital Management
Texas
$573K +$109K +3,650 +19%
T. Rowe Price Associates
42
T. Rowe Price Associates
Maryland
$549K +$746 +25 +0.1%
RFC
43
Russell Frank Company
Washington
$535K -$148K -4,962 -19%
Charles Schwab
44
Charles Schwab
California
$498K – – –
ACP
45
Acuta Capital Partners
California
$494K +$597K +20,000 New
MOACM
46
Mutual of America Capital Management
New York
$422K -$223K -7,474 -30%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$396K -$1.49K -50 -0.3%
Morgan Stanley
48
Morgan Stanley
New York
$344K -$117K -3,915 -22%
SO
49
STRS Ohio
Ohio
$339K – – –
USAA
50
United Services Automobile Association
Texas
$328K -$19.2K -644 -5%
1
2
3 4 5

RIGL Hedge Fund Activity: Q3 2015 in Review

122 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q3 2015, worth a combined $197M — down 22% from $253M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of RIGL and 9 opened new positions — a net loss of 1 holder — while 44 trimmed existing stakes and 41 added.

The largest buyer was Wellington Management Group, adding an estimated $2.6M. The largest seller was Broadfin Capital, cutting an estimated $2.24M.

  • 122 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q3 2015, down from 123 in Q2 2015.
  • Funds reported $197M of Rigel Pharmaceuticals stock for Q3 2015, down 22% quarter-over-quarter.
  • 9 funds opened new Rigel Pharmaceuticals positions in Q3 2015 and 10 closed out, a net change of -1 holder.
  • The largest Rigel Pharmaceuticals buyer in Q3 2015 was Wellington Management Group, an estimated $2.6M added.
  • The largest Rigel Pharmaceuticals seller in Q3 2015 was Broadfin Capital, an estimated $2.24M sold.

Based on aggregated 13F filings for Q3 2015.